FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Malgorzata Krych-Goldberg

Research Profile

Chemicals & Drugs

Physiology

Concepts & Ideas

Genes & Molecular Sequences

Procedures

Nuclear Magnetic Resonance, Biomolecular

Co-author Network

Publications

TOP 3
Malgorzata Krych-Goldberg; Richard Hauhart; Tina Porzukowiak; John P Atkinson
Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors.
Krystyna Bromek; Donghan Lee; Richard Hauhart; Malgorzata Krych-Goldberg; John P Atkinson; Paul N Barlow; Konstantin Pervushin
Polychromatic selective population inversion for TROSY experiments with large proteins.
Gordon Black; Michael Wenzler; Xuefeng Wang; Malgorzata Krych-Goldberg; John P Atkinson; Paul N Barlow
1H, 15N and 13C resonance assignments of complement control protein module pair 2-3 from the C4b-binding site of complement receptor type 1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Malgorzata Krych-Goldberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Malgorzata Krych-Goldberg; Richard Hauhart; Tina Porzukowiak; John P Atkinson
Synergy between two active sites of human complement receptor type 1 (CD35) in complement regulation: implications for the structure of the classical pathway C3 convertase and generation of more potent inhibitors.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(7):4528-35.
2005: Krystyna Bromek; Donghan Lee; Richard Hauhart; Malgorzata Krych-Goldberg; John P Atkinson; Paul N Barlow; Konstantin Pervushin
Polychromatic selective population inversion for TROSY experiments with large proteins.
Journal of the American Chemical Society 2005;127(1):405-11.
2004: Gordon Black; Michael Wenzler; Xuefeng Wang; Malgorzata Krych-Goldberg; John P Atkinson; Paul N Barlow
1H, 15N and 13C resonance assignments of complement control protein module pair 2-3 from the C4b-binding site of complement receptor type 1.
Journal of biomolecular NMR 2004;30(2):227-8.
2002: Andrew Herbert; J O'leary; Malgorzata Krych-Goldberg; John P Atkinson; Paul N Barlow
Three-dimensional structure and flexibility of proteins of the RCA family - a progress report.
Biochemical Society transactions 2002;30(Pt 6):990-6.
2002: Malgorzata Krych-Goldberg; Joann M Moulds; John P Atkinson
Human complement receptor type 1 (CR1) binds to a major malarial adhesin.
Trends in molecular medicine 2002;8(11):531-7.
2002: Brian O Smith; Rosie L Mallin; Malgorzata Krych-Goldberg; Xuefeng Wang; Richard Hauhart; Krystyna Bromek; Dusan Uhrin; John P Atkinson; Paul N Barlow
Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor.
Cell 2002;108(6):769-80.
2002: Joann M Moulds; Peter Zimmerman; Ogobara K Doumbo; Dapa A Diallo; John P Atkinson; Malgorzata Krych-Goldberg; Dennis E Hourcade; John J Moulds
Expansion of the Knops blood group system and subdivision of Sl(a).
Transfusion 2002;42(2):251-6.
2001: Joann M Moulds; Peter Zimmerman; Ogobara K Doumbo; L Kassambara; Issaka Sagara; Dapa A Diallo; John P Atkinson; Malgorzata Krych-Goldberg; Richard Hauhart; Dennis E Hourcade; David T McNamara; D J Birmingham; J Alexandra Rowe; John J Moulds; Louis H Miller
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1.
Blood 2001;97(9):2879-85.
2001: Malgorzata Krych-Goldberg; John P Atkinson
Structure-function relationships of complement receptor type 1.
Immunological reviews 2001;180():112-22.
2000: Dennis E Hourcade; M Kathryn Liszewski; Malgorzata Krych-Goldberg; John P Atkinson
Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
Immunopharmacology 2000;49(1-2):103-16.
1999: Malgorzata Krych-Goldberg; Richard Hauhart; VB Subramanian; B M Yurcisin; D L Crimmins; Dennis E Hourcade; John P Atkinson
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases.
The Journal of biological chemistry 1999;274(44):31160-8.